A Surprising Beneficiary of New Alzheimer’s Drugs: GE HealthCare
Wall Street Journal
Biogen, Eli Lilly drugs will expand the imaging market for companies in the diagnostics space.
https://www.wsj.com/articles/a-surprising-beneficiary-of-new-alzheimers-drugs-ge-healthcare-e7814f6a